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Background: Cardiopulmonary involvement in systemic sclerosis (SSc) is a poor prognostic
factor, due to pulmonary hypertension and right ventricular dysfunction. We assessed the
echocardiographic parameters of right ventricular (RV) function in SSc and correlated
echocardiographic ﬁndings to clinical features of the disease.
Methods: Thirty patients with SSc (cases) and 30 healthy, age-matched subjects (controls)
were studied. Echocardiography, including tissue Doppler imaging, was used to evaluate
cardiac function.
Results: Pulmonary hypertension could be documented in only 5 cases by Doppler echo,
using Bernoulli principle. RV diastolic function was signiﬁcantly deranged in cases. RV
systolic function and left ventricle (LV) diastolic function were also signiﬁcantly de-
ranged in the cases. RV thickness was increased in patients with SSc. There were no
signiﬁcant differences in the echocardiographic variables between diffuse and limited
subtypes of SSc. Myocardial performance index (MPI) of both ventricles were increased in
cases. We could demonstrate RV thickness as the single most important predictor of MPI
of both ventricles with sensitivity of 82% and speciﬁcity of 72% for RV-MPI and 63% for
LV-MPI. Diastolic function was not found to be affected by disease duration or Rodnan
skin score.
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Conclusion: Patients with SSc exhibit abnormal RV and LV diastolic functions as well as
abnormal RV systolic function. RV wall thickness was found to be simple and the single best
predictor of global myocardial performance. RV dysfunction may be a response to intermit-
tent pulmonary arterial hypertension, lung parenchymal involvement, or secondary to LV
diastolic dysfunction in SSc.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Systemic sclerosis (SSc) is a multisystem disorder character-
ized by extensive vascular damage and ﬁbrosis of the skin and
internal organs. Cardiac involvement occurs in a signiﬁcant
percentage (≤80%) of these patients.1 Cardiac involvement
consists of degeneration of myocardial ﬁbers and irregular
areas of interstitial ﬁbrosis that are most prominent around
blood vessels.2
Myocardial ﬁbrosis seems to start from the subendocar-
dium in SSc. Therefore, due to the subendocardial location of
the longitudinal myoﬁbrils, longitudinal functions and dia-
stolic parameters have particular signiﬁcance in determining
early myocardial involvement. The prognosis for patients with
SSc also correlates with the presence of pulmonary hyperten-
sion.2
There is a discrepancy between the frequency of clinically
evident myocardial disease (25%) and autoptical myocardial
ﬁbrosis (81%).3 Invasive and non-invasive diagnostic investi-
gations, as well as necropsy studies, showed that, in SSc,
cardiac involvement is one of the most frequent visceral
complications that can affect the overall prognosis of the
disease.4
The hemodynamic parameters of right ventricular (RV)
dysfunction, as measured by cardiac catheterization, are
strong predictors of outcome in patients with SSc.5,6 Denton
et al.7 have compared Doppler echocardiography vs. right
heart catheterization and found Doppler to be 90% sensitive
and 75% speciﬁc in detecting pulmonary hypertension as
compared to catheterization. However, it may underestimate
the true PA (pulmonary artery) pressure in absence of tricuspid
regurgitation. In the present study, we have applied the
technique of tissue Doppler in order to identify the TDI (tissue
Doppler imaging) markers of myocardial function.
2. Methods
2.1. Clinical
Seventy-two patients from Rheumatology Outpatient Clinic
with diagnosis of SSc according to American College of
Rheumatology criteria8 were screened, and of them, 30
patients were enrolled into the study. Thirty age- and
gender-matched healthy volunteers were selected for
comparison. Written informed consent was taken from
all subjects. The study was conducted for a period of
18 months in Rheumatology clinic of PGIMER. Patients
without sinus rhythm, known cardiomyopathies, IHD
(ischemic heart disease), signiﬁcant left-sided valvulardisease, CKD (chronic kidney disease) stage III or higher,
diabetics, prior cardiac surgery, Bundle branch block on ECG,
poor echo window, and those unwilling to give informed
consent were excluded.
Detailed history and clinical examination, including
Rodnan skin score,9 were done. Disease duration was
calculated based on either onset of symptoms of exertional
dyspnea, skin thickening, Raynaud's phenomenon, or physi-
cian-aided diagnosis of scleroderma. Pulmonary involvement
was deﬁned clinically by either dyspnea or bibasilar rales.
Renal function tests, LFT (liver function tests), ANA (antinu-
clear antobody), Chest X-ray, and pulmonary function tests
with diffusion capacity of carbon dioxide (DLCO) were done in
all patients.
2.2. Pulmonary function testing
All the patients underwent pulmonary function testing. FEV1/
FVC < 80% was classiﬁed as obstructive. In presence of normal
FEV1/FVC, FVC was used to classify restrictive pattern as mild
(<80–60%), moderate (<60–40%), and severe (<40%), as per our
laboratory standards. DLCO was adjusted for alveolar ventila-
tion and hematocrit by the following formula.10 Corrected
DLCO ¼ DLCO  ð10:22 þ HbÞ=1:7  Hb . . . . . . :in males and
Corrected DLCO¼DLCOð9:38þHbÞ=1:7Hb . . . . . . . . .in females
2.3. Cardiological investigations
Resting ECG was performed in all. Echocardiography was done
using ultrasound [Acuson Sequoia (C512)] equipped with a 4.0-
MHz (V4c; Acuson) transducer and DTI technology. The
examination was performed with the subject in the left lateral
decubitus position with normal breathing. All tracings were
recorded at the end-expiratory phase to reduce respiratory
variation. Standard two-dimensional parasternal and apical
projections were obtained. All recordings were performed with
a simultaneous superimposed phonocardiogram to detect the
pulmonary component of the second heart sound (S2) and
continuous EKG for pulmonary valve ﬂow recording. All
images were recorded at sweep speeds of 50 mm/s and
100 mm/s.
From M-mode echocardiography recordings, measurements
were made on consecutive three beats, according to recom-
mendations of the American Society of Echocardiography.11
The left ventricle (LV) mass was calculated using Devereux
formula.
Myocardial mass ¼ 1:04½ðLVID þ PWT þ IVSTÞ3  LVID3
 0:8 þ 0:6
where LVID is the internal dimension of LV, PWT is posterior
wall thickness, IVST is interventricular septal thickness, and
Fig. 1 – Calculation of Tei index.
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done in centimeters to get the mass in grams. The mass thus
obtained was divided with body surface area to get myocardial
mass index. The thickness of RV wall was measured from the
subcostal view at the peak of R wave.
2.4. Conventional Doppler echocardiography assessment
of global function
From the mitral and tricuspid velocity proﬁles, E/A ratio, E-
wave DT, and isovolumic relaxation time (IVRT) were made
according to the recommendations of the American Society of
Echocardiography. Velocity of tricuspid regurgitant jet (VTR)
was used to measure pulmonary artery systolic pressure.
Saline contrast was used to enhance TR jet if no TR jet was
seen on conventional Doppler. Pulmonary hypertension was
suspected on echocardiography when VTR was >2.8 m/s.
2.5. DTI assessment of regional myocardial RV function
Myocardial systolic and diastolic velocities were recorded
using the pulsed-wave DTI technique. Velocities were
obtained from the apical four-chamber view. The sample
volume was placed at lateral tricuspid annulus and lateral
tricuspid annular systolic velocity was measured. Similarly,
ventricular septal velocity and lateral mitral annular systolic
velocity were taken by placing sample volume at tricuspid
septal attachment and mitral lateral annulus, respectively. All
measurements were taken from three beats, and the mean
value was used.
The measured time intervals from Doppler and tissue
Doppler study were corrected for heart rate by dividing with
square root of R–R interval and also by another method of the
time interval taken as the proportion of R–R interval
(expressed as %) for comparison.
2.6. The Tei index
The Tei index12 was used to assess left and right global
ventricular function. As originally described by Tei,12 the time
intervals used to calculate the index were measured using
pulsed-wave Doppler velocity spectra of ventricular inﬂow
and outﬂow. Mitral or tricuspid ﬂow velocity spectra were
obtained by positioning the pulsed-wave Doppler sample
volume at the tips of the mitral or tricuspid valve leaﬂets in
the apical four-chamber view. Right ventricular outﬂow
velocity spectra are obtained from the parasternal short-axis
view, with the pulsed-wave Doppler sample volume posi-
tioned at the pulmonic annulus. Calculation of the Tei index
(Fig. 1) involves measuring the time interval a, extending from
the cessation of mitral or tricuspid inﬂow to its subsequent
onset; and ejection time b, which is the duration of the left or
right ventricular outﬂow velocity spectrum. As the time
intervals include the ICT, ET, and IRT, the Tei index can be
expressed as follows:
Tei index ¼ ðICT þ IRTÞ
ET
¼ ða  bÞ
b
:
Time intervals were measured at a sweep speed of 100 mm/
s and are averaged over at least 3–5 cardiac cycles.All the echocardiographic measurements were done by one
investigator, Dr Manoj Kumar Rohit, who was blinded for
patient proﬁle.
2.7. Statistical analysis
A commercially available statistical program (SPSS 15.0 for
windows; SPSS; Chicago, IL) was used. All data are presented as
mean  SD. An unpaired Student t-test was used to compare
data from patients and control subjects. Pearson correlations
were used to compare associations between indexes. Univariate
analysis was done to adjust for known confounding variables of
ventricular function. Linear and binary logistic regression
model was used to determine relationship between different
indices, and p < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Clinical proﬁle
Clinical proﬁle of age- and sex-matched subjects are presented
in Table 1.
3.2. Pulmonary function tests and HRCT
Clinical pulmonary involvement was present in 57%. Pulmo-
nary function tests results are in Table 2.
Mean DLCO was low in patient group (mean = 54.7 ml/min/
mmHg); however, when corrected for alveolar ventilation and
hematocrit, the mean was 103.7, suggesting that the decrease
was mainly due to reduced ventilation.
HRCT was available in 18 out of 30 patients, of which 17 was
suggestive of ILD.
3.3. LA and LV dimensions and functions
LA and LV size and LV systolic function were similar in both
groups (Table 3). However, there were signiﬁcant differences in
Table 1 – Patient characteristics and hemodynamic data.
Characteristics Case
(n = 30)
Controls
(n = 30)
p-value
Age, yrs 38.87  10.41 39.23  10.31 0.891
Female/male
gender (Number)
23/7 23/7
Height, cm 160.97  5.53 163.67  6.86 0.077
Weight, kg 55.63  8.42 55.9  8.99 0.906
BSA, m2 1.57  0.12 1.59  0.14 0.471
HR, beats/min 90  12 72  5 <0.001*
SBP, mmHg 125  20 122  10 0.542
DBP, mmHg 80  11 77  8 0.224
Median duration of
symptoms (in months)
48 (IQR 21–84) – –
Creatinine clearance
(ml/min/1.73 m2)
104  21 – –
Data presented as mean  SD, unless speciﬁed otherwise.
* Statistically signiﬁcant.
Table 2 – PFT findings of cases.
Frequency (%)
Normal 23.3
Restriction
Mild 23.3
Moderate 43.3
Severe 3.3
Obstruction
Mild 6.7
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measure of global LV function (Table 4). LV ejection fraction
was normal in both.
3.4. RV systolic function
There was signiﬁcant increase in the right ventricular free wall
thickness among patients. Both blood ﬂow derived andTable 3 – LV systolic function.
Characteristics Case (n =
2D and M Mode parameters
LV end systolic dimension, mm/m2 16.3  4
LV end diastolic dimensions, mm/m2 27  4
Fractional shortening, % 40  1
LV end systolic volume index, ml/m2 15.7  8
LV end diastolic volume index, ml/m2 44.8  1
LV ejection fraction, % 66  1
LV myocardial mass index, g/m2 85  2
Conventional Doppler echocardiographic measurements (global function
Isovolumic contraction time, ms 62.4  2
Isovolumic contraction time/R–R interval, % 9.5  3
Ejection time, ms 227  5
Tissue Doppler imaging (regional function)
Mitral annular systolic velocity, cm/s 22.8  4
Septal velocity, cm/s 20.3  3
Isovolumic contraction time, ms 55  1
Isovolumic contraction time/R–R interval, % 8.2  2
Modiﬁed Simpsons
LVEF, % 63  9
* Statistically significant.myocardium derived isovolumic contraction time (IVCT) were
prolonged in patients after correction for heart rate. Pulmo-
nary acceleration time was also signiﬁcantly reduced in the
patient group (Table 5).
3.5. RV diastolic function
Tricuspid regurgitation could be documented only in 7 cases;
out of which, 5 cases were found to have pulmonary
hypertension. By conventional Doppler measurement, tricus-
pid A velocity was found to be signiﬁcantly raised in patients
with corresponding decrease of E/A velocity. Both blood ﬂow
derived and myocardium derived IVRT were prolonged in the
patient group even after adjustment for heart rate (Table 6).
This difference persisted across various age groups in
subgroup analysis (Table 7). There was no signiﬁcant differ-
ence in DTI-derived RV-IVRTc among cases when categorized
by disease duration.
3.6. Global right ventricular performance
The MPI was signiﬁcantly raised in the patient group (0.54
+ 0.26 vs. 0.35 + 0.07, p < 0.001), suggesting overall diminished
right ventricular performance in patients.
3.7. Relationship between diastolic dysfunction and
clinical features
The indices of ventricular diastolic dysfunction for both
ventricles IVRT/RR (%) did not correlate to age, duration of
disease, skin score, hematocrit-corrected DLCO, or forced vital
capacity in the patient group. However, there was signiﬁcant
negative correlation between tricuspid E/A velocity and age
[r = (0.0393), p = 0.043]. RV free wall thickness positively
correlated with age (r = 0.444, p = 0.014), duration of disease
(r = 0.668, p < 0.001), and negatively correlated with PAT
(r = 0.381, p = 0.038) and tricuspid E/A (r = 0.573, p = 0.002). 30) Controls (n = 30) p-value
.16 15.6  2.2 0.441
 28.4  3.2 0.127
1 44.2  9 0.094
.6 15  3.7 0.687
4 47.4  9.5 0.416
0 68  4 0.208
6 91  12 0.346
)
2 52  10.5 0.024*
.7 6.2  1.3 <0.001*
0.4 284  31.2 <0.001*
.7 33  2.5 0.792
.7 19.7  2.9 0.512
8 59  8 0.286
.8 7.1  1.4 0.061
.5 69.4  7.4 0.006*
Table 4 – LV diastolic function.
Characteristics Case (n = 30) Controls (n = 30) p-value
Conventional Doppler echocardiographic measurements (global function)
Mitral E velocity, cm/s 61.13  20.13 73.31  12.91 0.007*
Mitral A velocity, cm/s 54.83  20.41 56.2  10.9 0.765
Mitral E/A 1.17  0.29 1.32  0.17 0.021*
DT, ms 160  47 236  58 <0.001*
IVRT, ms 74  24 53.5  12 <0.001*
IVRT/R–R interval, % 11.2  4 6.4  1.5 <0.001*
IVRT=
ﬃﬃﬃﬃﬃﬃ
RR
p
, ms 90.9  31 58.5  13 <0.001*
DTI (regional function)-lateral mitral annulus
IVRT, ms 60  20 58.4  7 0.794
IVRT/R–R interval, % 8.9  3.1 7  1.2 0.004*
IVRT=
ﬃﬃﬃﬃﬃﬃ
RR
p
, ms 72.5  24 64  8.7 0.078*
Global LV myocardial performance index
LV Tei index 0.42  0.15 0.40  0.07 0.474
* Statistically significant.
Table 5 – comparison of RV systolic function parameters
in cases and controls.
M MODE Case
(n = 30)
Controls
(n = 30)
p-value
RV thickness 6.7  1.3 5.3  0.7 <0.001
Conventional Doppler echocardiographic measurements (global
function)
PAT, ms 110  21 136  35 0.001*
IVCT, ms 60  23 48  12 0.017*
IVCT/R–R interval (%) 8  4 5.8  1.8 0.009*
DTI (regional function)-lateral tricuspid annulus
Lateral tricuspid annular
systolic velocity, cm/s
21.8  4.2 21.2  2.7 0.53
IVCT, ms 60  17.5 55  8.3 0.176
IVCT/R–R interval (%) 9  2.9 6.6  1.2 <0.001*
* Statistically significant.
Table 6 – RV diastolic function.
Conventional Doppler echocardiographic measurements (global
function)
Tricuspid E velocity, cm/s 49.8  11.4 49.6  6.3 0.935
Tricuspid A velocity, cm/s 48.7  10.6 38  7.3 <0.001*
Tricuspid E/A 1.04  0.2 1.32  0.19 <0.001*
DT, ms 174  67 232  67 0.002*
IVRT, ms 68.5  21.1 42.6  5.8 <0.001*
IVRT/R–R interval, % 9.3  4.7 5.1  0.7 <0.001*
DTI (regional function)-RV free wall
IVRT, ms 67.1  21.3 46.6  12.2 <0.001*
IVRT/R–R interval, % 10.1  3.5 5.6  1.7 <0.001*
Tei index
RV Tei index 0.54  0.26 0.35 0.07 <0.001*
* Statistically significant.
Table 7 – Mean lateral tricuspid IVRT/RR (%) in cases and contr
Age groups Cases Con
<35 yrs 9.5  4.23 (n = 11) 5.44  1
35–44 yrs 9.74  3.52 (n = 8) 5.6  1
>45 yrs 11  2.7 (n = 11) 5.8  2
* Statistically significant.
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corrected DLCO (r = 0.403, p = 0.027) and LV-Tei (r = 0.457,
p = 0.011). The diastolic parameter of the two ventricles
measured by TDI-derived IVRT/RR (%) also showed good
correlation among themselves (r = 0.667, p < 0.001).
4. Discussion
In the present study, we were able to demonstrate that in
patients with SSc, diastolic function of both ventricles were
signiﬁcantly deranged.
The RV dysfunction here is clearly evidenced by prolonged
global and regional IVRT as well as signiﬁcantly reduced
tricuspid E/A velocity derived from 2-D Doppler; however,
signiﬁcantly reduced tricuspid DT and mean E/A, which is >1,
suggest that there is grade II diastolic dysfunction as deﬁned
by the Canadian consensus recommendations. The advanced
dysfunction is also supported by markers of early systolic
dysfunction of RV, which is usually affected late in natural
course of SSc.
Two factors are known to cause changes in diastolic
function of RV: age and increased heart rate that is usual in SSc
due to sympathetic activation. We have matched our cases
with controls with respect to age, and all the time intervals
were corrected for change in heart rate. Similarly, RV diastolic
dysfunction was not correlated with skin score, duration of
disease, or any of the PFT markers of abnormal lung function.
The only marker signiﬁcantly affected with hematocrit-
corrected DLCO was RV-MPI, a marker of global function of
RV (r = 0.403, p = 0.027).
Since the prognosis for patients with SSc correlates
well with the presence of pulmonary hypertension,2 andols.
trols Mean difference p-value
.9 (n = 8) 4.01 0.023*
.4 (n = 13) 4.15 0.001*
 (n = 9) 5.2 <0.001*
Fig. 2 – ROC curve showing sensitivity and specificity of RV
wall thickness in predicting RV-MPI.
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patients (51.6% in one series involving 31 patients13), mea-
surement of pulmonary arterial pressure seems to be of great
value. In our study, there were only 5 cases in which
pulmonary hypertension could be predicted by taking TR jet
velocity into account. What was interesting is that even when
we excluded those 5 cases from our analysis, there were
signiﬁcant differences between cases and control group in the
above-mentioned parameters of RV diastolic function, sug-
gesting either pulmonary hypertension is not the only factor
responsible for diastolic dysfunction or the methodology
applied to detect it is not sensitive enough. With literature
search, both of these seem true. It is well known that Doppler
echocardiography may underestimate pulmonary artery pres-
sure when obtained from tricuspid regurgitation peak veloci-
ty.14–16 Similarly, apart from pulmonary hypertension,
myocardial ﬁbrosis and ischemia, which are the hallmarks
of disease, can signiﬁcantly affect myocardial function in these
patients. It has been shown in studies that intermittent
coronary vasospasm is prevalent in SSc.17 The pattern of
diastolic dysfunction seen in patients can thus be related to
myocardial ﬁbrosis and/or ischemia, both of which are known
to affect ventricular relaxation and ﬁlling. This mechanism of
dysfunction is also supported by ﬁnding of left ventricular
diastolic dysfunction in the present study in the absence of
hypertension.
Pulmonary involvement is one of the leading causes of
death in SSc. While pulmonary arterial hypertension is
commonly seen in long standing limited type of SSc,
interstitial pulmonary ﬁbrosis by alveolitis is more common
in diffuse type. Since Doppler is not good modality at detecting
PAH, mild or early PAH cannot be ruled out in our patient
group, and Raynaud's phenomenon in lung is a possibility.
This is supported by reduced pulmonary acceleration time,
which is documented to be inversely correlated to pulmonary
artery systolic pressure in invasive measurements (r = 0.85
with pulmonary artery systolic pressure (PASP))18 and in-
creased RV wall thickness, suggesting increased after load of
RV.
There was signiﬁcant prolongation of IVCT with reduction
of ejection time both by Doppler-derived global and TDI-
derived regional time intervals, suggesting an early RV systolic
dysfunction. RV systolic dysfunction occurs late in the natural
course of disease only when disease progresses to involve
circular muscle ﬁbers of myocardium. Though RV systolic
dysfunction is not very well documented in older literature,19–
21 Hsiao et al.22 found signiﬁcant RV systolic dysfunction
(RVEF < 40%) in 55% of 40 patients studied.
We could also demonstrate signiﬁcant LV diastolic dys-
function in our patients. In contrast to earlier studies, where
the involvement was early with reduction of E/A to <1 and
prolongation of deceleration time,23,24 in our study mitral E/A
was >1 with signiﬁcant reduction of DT. In combination with
signiﬁcantly prolonged global MPI and IVRT (both global and
regional), above-mentioned LV time intervals will suggest a
pseudo-normalized mitral ﬁlling pattern. It has been well
known that the diastolic function of the LV is affected by age
and hypertension but the difference persisted in the patient
group even after adjusting for age and blood pressure. Thirteen
patients were using ACE inhibitors at the time of study andthere was no signiﬁcant difference in diastolic time intervals
and MPI between those who were on drugs (n = 13) vs. those
who were not on drugs (n = 17) ( p = 0.216).
Recently, Codullo et al.25 had reported exercise-induced
change in pulmonary artery systolic pressure (DPASP >
18 mmHg) as a predictor of development of PAH over a mean
follow-up of 3.5 yrs. However, there is heterogeneity of
underlying mechanism of DPASP and this was shown to be
due to rise in pulmonary vascular resistance in only 11% of
cases.26One invasive study involving right heart catheterization
has shown the change in PASP is predominantly due to LV
diastolic dysfunction than pulmonary arterial vasculopathy.27
Hence, the signiﬁcance of this new marker too remains
uncertain. However, all these studies reinforce the need for
assessment of pulmonary hypertension at an early stage.
Enriquez-Sarano found signiﬁcant negative correlation
between pulmonary artery systolic pressure and mitral
deceleration time (r = 0.61, p = 0.0001).28 Similarly, Tei index
signiﬁcantly correlated with invasive measurements of ven-
tricular function in porcine model.29 Recently in humans too, a
strong positive correlation was found between invasively
measured PASP- and DTI-derived IVRTc (r = 0.86), blood pool-
derived IVRTc (r = 0.75), and Endothelin-1 levels (r = 0.94); and
between DTI-derived IVRTc and ET-1 levels (r = 0.82); p < 0.001
for all correlations.30 As Tei index was found to be a reliable
predictor of ventricular function, we tried to ﬁnd out more
simple predictors of Tei index in our cohort.
We determined normal cut-offs of Tei index in our
population. Upper limit of normal was deﬁned as mean + 2
SE of mean (95% conﬁdence interval). By logistic regression
analysis, we found that right ventricular free wall thickness
was the single most important predictor for differentiating
abnormal from normal Tei index. By ROC curve analysis, it was
found that RV thickness of 6 mm or more can predict abnormal
RV-MPI with a sensitivity of 82% and speciﬁcity of 72% (area
under curve 0.838, p < 0.001) (Fig. 2).
The same cut-off for RV thickness of 6 mm could distin-
guish abnormal LV-MPI from normal with sensitivity of 82%
and speciﬁcity of 63% (area under curve 0.769, p = 0.001) (Fig. 3).
There are many studies in the past that have studied the
heart in SSc and have found signiﬁcant differences in the
echocardiographic parameters in patients with SSc as com-
pared to controls19,31,32; most of the studies were having
Fig. 3 – ROC curve showing trade-off between sensitivity
and specificity when RV thickness was used as predictor of
LV-MPI.
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pulmonary hypertension by tricuspid jet peak velocity
calculations. Our study differs in that; we showed a signiﬁcant
disturbance in biventricular function in a sample that has very
few (16.7%) patients having pulmonary hypertension by
conventional Doppler methods, and the signiﬁcance remained
even when this 16.7% was excluded from analysis. This goes in
favor of observations made in earlier studies that Doppler may
underestimate PASP and demands for need of non-invasive
methods for determination of pulmonary artery pressure and
ventricular performance. Tissue Doppler seems to be an
important step towards achieving this goal and it seems
reasonable to assess ventricular function in detail in all
patients with SSc.
5. Limitations
We were careful to clinically exclude patients with concomi-
tant conditions that would potentially confound interpreta-
tion of two-dimensional and Doppler indices. Although
vasoactive medications were not discontinued and hyperten-
sion was not excluded, our ﬁndings were independent of these
inﬂuences. We did not measure pulmonary venous ﬂow in
systole and diastole and neither Valsalva maneuver during the
echocardiography, which could have reliably differentiated
normal from pseudo-normal diastolic ﬁlling pattern; however,
the existing data are sufﬁcient to distinguish between the two.
We were not able to see the relationship of echo parameters
with HRCT ﬁndings, as HRCT in all patients was not allowed by
local ethics committee and HRCT was available with only 18
out of 30 patients. Correlation with HRCT ﬁndings were thus
not attempted to avoid selection bias. We did not perform right
heart catheterization to verify diastolic function and PA
pressures. However, some of the echocardiographic parame-
ters used in the present study are well-validated11. Direct
evidence of myocardial ﬁbrosis can only be veriﬁed by
myocardial biopsy, but an investigation of this kind is notethical in this group of patients. The sample size was small as
many patients were excluded due to poor echo window
secondary to skin involvement, and some due to early
occurrence of atrial ﬁbrillation, and this has limited the
number in all other previously published studies too.
6. Conclusion
In the present study, pulmonary hypertension was detected in
only 5 out of 30 patients (16.7%) of SSc by Doppler-deﬁned
parameters taking tricuspid regurgitant peak velocity.
Both RV and LV diastolic functions were signiﬁcantly
deranged in patients compared to controls, and the difference
persisted even after excluding those 5 patients with Doppler-
proven PAH from analysis, suggesting that PASP determina-
tion by Doppler alone may underestimate true prevalence of
cardiopulmonary involvement.
Tei index has been proven to be a marker of global and
regional myocardial performance by invasive studies, and
here we could demonstrate RV thickness as a single most
important predictor of Tei index of both ventricles.
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